Tag

Ro

All articles tagged with #ro

Chrissy Metz’s GLP-1 Journey: From Skepticism to Cravings Relief and Stamina Boost
health2 hours ago

Chrissy Metz’s GLP-1 Journey: From Skepticism to Cravings Relief and Stamina Boost

Chrissy Metz reveals she’s started a GLP-1 medication through Ro after initial skepticism. She says the therapy has quieted her food thoughts, boosted stamina for eight shows a week on Broadway, and even improved inflammation and joint comfort, with her menstrual cycle regulating and body measurements changing enough to require costume tweaks. Metz stresses it isn’t a magic fix, urges careful research and doctor consultation, and notes she expects scrutiny while pursuing long‑term health, including considerations around perimenopause.

Romania names Adrian Vestea as prime minister after rival withdraws
world1 month ago

Romania names Adrian Vestea as prime minister after rival withdraws

Romania’s centrist President Nicusor Dan designated Adrian Vestea, Brasov county council president, as prime minister after independent candidate Eugen Tomac withdrew his bid to form a government. Dan said a political solution is the right path, giving Vestea 10 days to form a government and secure a parliamentary vote. A minority government is seen by some as preferable to a technocratic one; the next election is due in 2028, with an early vote unlikely despite the opposition far-right leading polls.

Eli Lilly Partners with Ro to Offer Affordable Zepbound via Telehealth
health1 year ago

Eli Lilly Partners with Ro to Offer Affordable Zepbound via Telehealth

Ro, a direct-to-consumer health-care startup, has partnered with Eli Lilly to offer more affordable single-dose vials of the weight loss drug Zepbound. This integration allows patients to receive a diagnosis, prescription, and home delivery of Zepbound through Ro's platform, streamlining access to the drug. The vials, available via LillyDirect, are a cash-pay product and cost significantly less than the autoinjector form, making them more accessible to uninsured patients. This move aims to expand access to branded Zepbound and counter the rise of cheaper compounded versions.